Bioprocess Solutions Division

GenScript simplifies antibody purification process

23-Jan-2019 By Maggie Lynch

Gene synthesis provider, GenScript, launched its new purification instrument, AmMag SA, to simplify purification processes and reduce time invested.

CHO cells the 1900s model car in a 2020 Tesla world, says Dyadic

24-Sep-2018 By Flora Southey

Dyadic’s CHO-alternative, the C1 production platform, could reduce time and cost at almost every stage of the cell development and biomanufacturing process, says CEO.

Sartorius talks M&A as it looks to more than double revenues by 2025

27-Feb-2018 By Dan Stanton

Sartorius expects its Bioprocess Solutions Division to make €2.8bn ($3.4bn) annually by 2025 through a mix of organic growth and technology bolt-ons.

Single-use once again growth engine for Sartorius

31-Jan-2017 By Staff Reporter

Sartorius reported a 22% year-on-year growth in sales in its bioprocessing division, driven by continued demand for single-use systems.

Sartorius pumping over €100m into production network to support growth

22-Apr-2016 By Dan Stanton

Sartorius will invest around 10% of its annual revenues into its manufacturing network to support continued double-digit growth of its bioprocessing equipment business.

Single-use, double-digits: Sartorius riding high on disposable demand

03-Feb-2016 By Dan Stanton

Single-use bioprocessing equipment was again the main growth driver for Sartorius, the firm says as it reports a 16% jump in sales for 2015.

Company Results

Sartorius: Single-Use Demand in Europe and Asia Offsets Rev Decline North America

26-Jul-2013

Increased demand for single-use tech from Europe and Asia offset lower North American sales and help Sartorius’ bioprocess solutions division drive company-wide growth.